An outcomes-based definition of proteinuria remission in focal segmental glomerulosclerosis

Clinical Journal of the American Society of Nephrology

Volumn 13, Issue 3, 2018, Pages 414-421

  Troost, Jonathan P ^a   Trachtman, Howard ^a   Nachman, Patrick H ^a   Kretzler, Matthias ^a   Spino, Cathie ^a   Komers, Radko ^a   Tuller, Sarah ^a   Perumal, Kalyani ^a   Massengill, Susan F ^a   Kamil, Elaine S ^a   Oh, Gia ^a   Selewski, David T ^a   Gipson, Patrick ^a   Gipson, Debbie S ^a  

^a NONE

Author keywords

Cohort Studies; Creatinine; Fsgs; Glomerular filtration rate; Goals; Humans Glomerulosclerosis, Focal Segmental; Kidney; Kidney Failure, Chronic; Prognosis; Propensity Score; Proportional Hazards Models; Proteinuria; Renal Insufficiency; Surrogate endpoint

Indexed keywords

CYCLOSPORINE; DEXAMETHASONE; MYCOPHENOLIC ACID; BIOLOGICAL MARKER; CREATININE;

ACCURACY; ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DEMOGRAPHY; DIALYSIS; DISEASE ACTIVITY; ESTIMATED GLOMERULAR FILTRATION RATE; EVALUATION AND FOLLOW UP; FEMALE; FOCAL GLOMERULOSCLEROSIS; HEALTH CARE SYSTEM; HUMAN; KAPLAN MEIER METHOD; KIDNEY BIOPSY; KIDNEY FUNCTION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEPHROLOGY; OUTCOME ASSESSMENT; PERCEPTIVE DISCRIMINATION; PHENOTYPE; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; PROTEINURIA; RECEIVER OPERATING CHARACTERISTIC; REMISSION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS; YOUNG ADULT; ADOLESCENT; BIOASSAY; CHILD; CHRONIC KIDNEY FAILURE; COMPLICATION; DISEASE EXACERBATION; GLOMERULUS FILTRATION RATE; OBSERVATIONAL STUDY; PATHOPHYSIOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME; URINE; VALIDATION STUDY;

ADOLESCENT; ADULT; BIOMARKERS; CHILD; CREATININE; DISEASE PROGRESSION; ENDPOINT DETERMINATION; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OBSERVATIONAL STUDIES AS TOPIC; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEINURIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; ROC CURVE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85043304435     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04780517     Document Type: Article

References (17)

1. United States Renal Data System: 2015 USRDS Annual Data Report: Epidemiology of Kidney isease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2015
2. KDIGO: Kidney Disease: Improving Global Outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl 2: 139–274, 2012
3. Han KH, Kim SH: Recent advances in treatments of primary focal segmental glomerulosclerosis in children. BioMed Res Int 2016. Available at https://www.hindawi.com/journals/bmri/2016/3053706/. Accessed April 17, 2017
4. Spino C, Jahnke JS, Selewski DT, Massengill S, Troost J, Gipson DS: Changing the paradigm for the treatment and development of new therapies for FSGS. Front Pediatr 4: 25, 2016
5. Trachtman H: Efficacy and safety of RE-021, a dual endothelin receptor and angiotensin receptor blocker, in patients with focal segmental glomerulosclerosis (FSGS): A randomized, double-blind, active-control, dose-escalation study (2012). Available at https://clinicaltrials.gov/ct2/show/NCT01613118. Accessed April 17, 2017
6. Thompson A, Cattran DC, Blank M, Nachman PH: Complete and partial remission as surrogate end points in membranous nephropathy. J Am Soc Nephrol 26: 2930–2937, 2015
7. Levey AS, Cattran D, Friedman A, Miller WG, Sedor J, Tuttle K, Kasiske B, Hostetter T: Proteinuria as a surrogate outcome in CKD: Report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis 54: 205–226, 2009
8. Gipson DS, Chin H, Presler TP, Jennette C, Ferris ME, Massengill S, Gibson K, Thomas DB: Differential risk of remission and ESRD in childhood FSGS. Pediatr Nephrol 21: 344–349, 2006
9. Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC; Toronto Glomerulonephritis Registry Group: Focal and segmental glomerulosclerosis: Definition and relevance of a partial remission. J Am Soc Nephrol 16: 1061–1068, 2005
10. Gadegbeku CA, Gipson DS, Holzman LB, Ojo AO, Song PX, Barisoni L, Sampson MG, Kopp JB, Lemley KV, Nelson PJ, Lienczewski CC, Adler SG, Appel GB, Cattran DC, Choi MJ, Contreras G, Dell KM, Fervenza FC, Gibson KL, Greenbaum LA, Hernandez JD, Hewitt SM, Hingorani SR, Hladunewich M, Hogan MC, Hogan SL, Kaskel FJ, Lieske JC, Meyers KE, Nachman PH, Nast CC, Neu AM, Reich HN, Sedor JR, Sethna CB, Trachtman H, Tuttle KR, Zhdanova O, Zilleruelo GE, Kretzler M: Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. Kidney Int 83: 749–756, 2013
11. Gipson DS, Trachtman H, Kaskel FJ, Greene TH, Radeva MK, Gassman JJ, Moxey-Mims MM, Hogg RJ, Watkins SL, Fine RN, Hogan SL, Middleton JP, Vehaskari VM, Flynn PA, Powell LM, Vento SM, McMahan JL, Siegel N, D’Agati VD, Friedman AL: Clinical trial of focal segmental glomerulosclerosis in children and young adults. Kidney Int 80: 868–878, 2011
12. C-PROBE: The clinical pehnotyping resource and biobank core (2017). Available at https://kidneycenter.med.umich.edu/c-probe-core. Accessed April 17, 2017
13. Santín S, Bullich G, Tazón-Vega B, García-Maset R, Giménez I, Silva I, Ruíz P, Ballarín J, Torra R, Ars E: Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 6: 1139–1148, 2011
14. Inker LA, Mondal H, Greene T, Masaschi T, Locatelli F, Schena FP, Katafuchi R, Appel GB, Maes BD, Li PK, Praga M, Del Vecchio L, Andrulli S, Manno C, Gutierrez E, Mercer A, Carroll KJ, Schmid CH, Levey AS: Early change in urine protein as a surrogate end point in studies of IgA nephropathy: An individual-patient meta-analysis. Am J Kidney Dis 68: 392–401, 2016
15. Remuzzi G, Benigni A, Remuzzi A: Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 116: 288–296, 2006
16. Mariani LH, Martini S, Barisoni L, Canetta PA, Troost JP, Hodgin JB, Palmer M, Rosenberg AZ, Lemley KV, Chien HP, Zee J, Smith A, Appel GB, Trachtman H, Hewitt SM, Kretzler M, Bagnasco SM: Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies [published online aheadof print February 27, 2017]. Nephrol Dial Transplant doi:10.1093/ndt/gfw443
17. Chen YE, Korbet SM, Katz RS, Schwartz MM, Lewis EJ; Collaborative Study Group: Value of a complete or partial remission in severe lupus nephritis. Clin J Am Soc Nephrol 3: 46–53, 2008